International Psoriasis Council
Under the title, What’s Next in Psoriasis? From Maintenance to Disease Modification, the 2022 IPC Think Tank scientific symposium was
Biologics and biosimilars have created many new options in psoriasis treatment for patients worldwide, but patients worldwide face barriers to
In the April 2021 issue of the Lancet, four of our esteemed colleagues in the IPC published an updated and
According to a new paper published by the team behind the PsoProtect registry, psoriasis patients treated with biologics are at